Annual Report 2025-26 filed with BSE

Pat NegativeRevenue DeclineRelated Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.2%Reaction day

₹154.10

prior close

₹160.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-5.6% vs market

Pharmaceuticals peers, median of 168sector+0.4%-4.6% vs sector

On the reaction day the stock moved 5.6 pts less than Nifty Microcap 250 and 4.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.2+1.4-5.6+0.4-4.6

Next day

+0.5+1.5-1.0+0.8-0.3

-0.3+0.5-0.8+0.5-0.8

-3.3+1.1-4.4+0.6-3.9

-2.9+0.7-3.6+0.5-3.4

-2.8-0.4-2.4-0.7-2.1

-0.3+0.5-0.9+0.3-0.6

15d

-0.7+0.1-0.8-1.8+1.1

+0.1+3.5-3.4-0.7+0.8

—+5.8—+2.2—

—+2.4—-1.6—

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Makers Laboratories filed its Annual Report for the year ended 31 March 2026. Total income fell to Rs 5094.01 lacs from Rs 5386.81 lacs last year, a drop of about 5 percent. The company swung to a loss with PAT of minus Rs 171.98 lacs versus a profit of Rs 464.11 lacs in the prior year. EPS turned negative at minus Rs 2.91 against Rs 7.87. Book value eased to Rs 92.25 from Rs 95.04. The 41st AGM is set for 7 August 2026 via video conferencing. A related party transaction with Ipca Laboratories up to Rs 30 crores is up for shareholder approval.

Likely market impact

Revenue slipped and the company moved from profit to loss versus last year. A related party deal with Ipca Labs needs shareholder nod at the AGM.